Literature DB >> 4555384

Clinical and pharmacological studies with 5-hydroxy-2-formylpyridine thiosemicarbazone.

R C DeConti, B R Toftness, K C Agrawal, R Tomchick, J A Mead, J R Bertino, A C Sartorelli, W A Creasey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4555384

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  10 in total

1.  Cytotoxic Evaluation of 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone, 3-AP, in Peripheral Blood Lymphocytes of Patients with Refractory Solid Tumors using Electron Paramagnetic Resonance.

Authors:  Jill M Kolesar; Kamakshi Sachidanandam; William R Schelman; Jens Eickhoff; Kyle D Holen; Anne M Traynor; Dona B Alberti; James P Thomas; Christopher R Chitambar; George Wilding; William E Antholine
Journal:  Exp Ther Med       Date:  2011-01       Impact factor: 2.447

2.  Identification of the di-pyridyl ketone isonicotinoyl hydrazone (PKIH) analogues as potent iron chelators and anti-tumour agents.

Authors:  Erika M Becker; David B Lovejoy; Judith M Greer; Ralph Watts; Des R Richardson
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

Review 3.  Iron-targeting antitumor activity of gallium compounds and novel insights into triapine(®)-metal complexes.

Authors:  Christopher R Chitambar; William E Antholine
Journal:  Antioxid Redox Signal       Date:  2012-10-03       Impact factor: 8.401

4.  Electron paramagnetic resonance study of peripheral blood mononuclear cells from patients with refractory solid tumors treated with Triapine.

Authors:  Jill M Kolesar; William R Schelman; Peter G Geiger; Kyle D Holen; Anne M Traynor; Dona B Alberti; James P Thomas; Christopher R Chitambar; George Wilding; William E Antholine
Journal:  J Inorg Biochem       Date:  2007-10-30       Impact factor: 4.155

5.  Effects of iron depletion on CALM-AF10 leukemias.

Authors:  Catherine P Lavau; Daniel S Wechsler; Jessica L Heath; Joshua M Weiss
Journal:  Exp Hematol       Date:  2014-09-03       Impact factor: 3.084

6.  ESR of copper and iron complexes with antitumor and cytotoxic properties.

Authors:  W E Antholine; B Kalyanaraman; D H Petering
Journal:  Environ Health Perspect       Date:  1985-12       Impact factor: 9.031

Review 7.  Iron deprivation in cancer--potential therapeutic implications.

Authors:  Jessica L Heath; Joshua M Weiss; Catherine P Lavau; Daniel S Wechsler
Journal:  Nutrients       Date:  2013-07-24       Impact factor: 5.717

8.  Schiff base derived from thiosemicarbazone and anthracene showed high potential in overcoming multidrug resistance in vitro with low drug resistance index.

Authors:  Jie Bai; Rui-Hui Wang; Yan Qiao; Aidong Wang; Chen-Jie Fang
Journal:  Drug Des Devel Ther       Date:  2017-07-31       Impact factor: 4.162

9.  Tumor-associated macrophages and individual chemo-susceptibility are influenced by iron chelation in human slice cultures of gastric cancer.

Authors:  Sebastian Prill; Jakob Rebstock; Anja Tennemann; Justus Körfer; Rasmus Sönnichsen; René Thieme; Ines Gockel; Orestis Lyros; Astrid Monecke; Christian Wittekind; Arved Weimann; Kerstin Grosser; Volker Wiechmann; Christoph Kubick; Ingo Bechmann; Florian Lordick; Sonja Kallendrusch
Journal:  Oncotarget       Date:  2019-07-30

10.  Comparison of metabolic pathways of different α-N-heterocyclic thiosemicarbazones.

Authors:  Karla Pelivan; Lisa M Frensemeier; Uwe Karst; Gunda Koellensperger; Petra Heffeter; Bernhard K Keppler; Christian R Kowol
Journal:  Anal Bioanal Chem       Date:  2018-02-23       Impact factor: 4.142
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.